You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


EC approval for Ontozry

Angelini Pharma has announced European Commission (EC) approval for anti-seizure drug Ontozry (cenobamate).